Malignancies Associated with Treatment of Rheumatic Diseases - to be or not to be
- *Corresponding Author:
- Sur Genel
University of Medicine and Pharmacy
Iuliu Hatieganu, Cluj-Napoca, Romania
E-mail: [email protected]
Received Date: October 03, 2013; Accepted Date: April 26, 2014; Published Date: May 03, 2014
Citation: Lucia SM, Genel S, Emanuela F, Daniel S (2014) Malignancies Associated with Treatment of Rheumatic Diseases - to be or ot to be. J Bioequiv Availab 6: 078-079. doi: 10.4172/jbb.10000184
Copyright: © 2014 Lucia SM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Malignancies associated with rheumatic diseases are more common than healthy individuals. What is actually the cause of increased malignancies in rheumatic diseases: autoimmunity, inflammation, immune regulation deficits? There was no a clear answer, but malignancies associated with rheumatic diseases is a certainty. Medication is also involved in the development of malignancies. Therefore we decided to address the involvement of rheumatic diseases medication in malignancies development.